PHASE II TRIAL OF DASATINIB FOR RECURRENT GLIOBLASTOMA (RTOG 0627) Conference

Lassman, Andrew, Wang, Meihua, Gilbert, Mark et al. (2008). PHASE II TRIAL OF DASATINIB FOR RECURRENT GLIOBLASTOMA (RTOG 0627) . NEURO-ONCOLOGY, 10(5), 824-824.

cited authors

  • Lassman, Andrew; Wang, Meihua; Gilbert, Mark; Aldape, Kenneth; Wright, John; Wagner, Henry; Brachman, David; Malkin, Mark; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 20, 2008 -

publication date

  • October 1, 2008

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Las Vegas, NV

Conference

  • 13th Annual Meeting of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 824

end page

  • 824

volume

  • 10

issue

  • 5